Business Description
Xilong Scientific Co Ltd
NAICS : 325998
SIC : 2899
ISIN : CNE1000013M8
Description
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.41 | |||||
Equity-to-Asset | 0.47 | |||||
Debt-to-Equity | 0.51 | |||||
Debt-to-EBITDA | 8.61 | |||||
Interest Coverage | 3.99 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 3.39 | |||||
Beneish M-Score | -2.58 | |||||
WACC vs ROIC |
Growth Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 12.6 | |||||
3-Year EBITDA Growth Rate | -1.3 | |||||
3-Year EPS without NRI Growth Rate | 35.7 | |||||
3-Year Book Growth Rate | 5.2 |
Momentum Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 32.78 | |||||
9-Day RSI | 36.64 | |||||
14-Day RSI | 41.37 | |||||
6-1 Month Momentum % | 54.43 | |||||
12-1 Month Momentum % | -8.99 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.59 | |||||
Quick Ratio | 1.26 | |||||
Cash Ratio | 0.22 | |||||
Days Inventory | 28.48 | |||||
Days Sales Outstanding | 59.29 | |||||
Days Payable | 45.2 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 0.69 | |||||
Dividend Payout Ratio | 0.11 | |||||
Forward Dividend Yield % | 0.69 | |||||
5-Year Yield-on-Cost % | 0.69 | |||||
Shareholder Yield % | 1.48 |
Profitability Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 6.33 | |||||
Operating Margin % | 2.37 | |||||
Net Margin % | 0.81 | |||||
FCF Margin % | -0.73 | |||||
ROE % | 2.93 | |||||
ROA % | 1.41 | |||||
ROIC % | 4.84 | |||||
ROC (Joel Greenblatt) % | 6.65 | |||||
ROCE % | 5.08 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 63.75 | |||||
PE Ratio without NRI | 41.13 | |||||
Shiller PE Ratio | 43.85 | |||||
PEG Ratio | 9.35 | |||||
PS Ratio | 0.49 | |||||
PB Ratio | 1.93 | |||||
Price-to-Tangible-Book | 2.08 | |||||
EV-to-EBIT | 37.61 | |||||
EV-to-EBITDA | 37.61 | |||||
EV-to-Revenue | 0.61 | |||||
EV-to-FCF | -83.61 | |||||
Price-to-DCF (Earnings Based) | 1.32 | |||||
Price-to-Median-PS-Value | 0.49 | |||||
Price-to-Graham-Number | 1.96 | |||||
Price-to-Net-Current-Asset-Value | 5 | |||||
Earnings Yield (Greenblatt) % | 2.66 | |||||
FCF Yield % | -1.39 | |||||
Forward Rate of Return (Yacktman) % | -4.11 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Xilong Scientific Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ¥) | 8,455.43 | ||
EPS (TTM) (Â¥) | 0.12 | ||
Beta | 1.32 | ||
Volatility % | 44.67 | ||
14-Day RSI | 41.37 | ||
14-Day ATR (Â¥) | 0.463378 | ||
20-Day SMA (Â¥) | 8.441 | ||
12-1 Month Momentum % | -8.99 | ||
52-Week Range (Â¥) | 5.35 - 11.85 | ||
Shares Outstanding (Mil) | 585.22 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Xilong Scientific Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Xilong Scientific Co Ltd Stock Events
Event | Date | Price(Â¥) | ||
---|---|---|---|---|
No Event Data |
Xilong Scientific Co Ltd Frequently Asked Questions
What is Xilong Scientific Co Ltd(SZSE:002584)'s stock price today?
When is next earnings date of Xilong Scientific Co Ltd(SZSE:002584)?
Does Xilong Scientific Co Ltd(SZSE:002584) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |